Benzenesulfonamide

Benzenesulfonamide

SCHEMBL3640561

COc1ccc(CNC=O)c(OC)c1.NS(=O)(=O)c1ccccc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.52
TP53 P04637 1/20 0.48
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
CA1 P00915 6/20 0.46
CA2 P00918 6/20 0.46
HPGD P15428 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CA4 P22748 2/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
MAPT P10636 1/20 0.43
CA7 P43166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL712690 0.84 APLNR (0.72) APLNRTP53MEN1KMT2AALDH1A1
SCHEMBL28279207 0.77 TP53 (0.67) APLNRTP53MEN1KMT2AALDH1A1
SCHEMBL5543280 0.74 APLNR (0.59) APLNRMEN1KMT2AALDH1A1KDM4E
SCHEMBL568210 0.74 SMN1; SMN2 (0.47) APLNRTP53ALDH1A1KDM4EPOLB
SCHEMBL5542552 0.73 APLNR (0.53) APLNRMEN1KMT2APOLBHTR2A
SCHEMBL28415525 0.73 ALDH1A1 (0.54) ALDH1A1CA1CA2HPGDCA12
SCHEMBL20286051 0.72 APLNR (0.53) APLNRMEN1KMT2AHTR2AHTR2C
SCHEMBL28043790 0.72 APLNR (0.69) APLNRTP53MEN1KMT2AALDH1A1
SCHEMBL350875 0.71 ALDH1A1 (0.58) TP53MEN1KMT2AALDH1A1KDM4E
SCHEMBL8724130 0.71 APLNR (0.73) APLNRTP53MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173743-A2 SODIUM CHANNEL INHIBITORS Icagen, Inc. (US) 2010-04-14 EP disclosed
WO-2009012242-A2 SODIUM CHANNEL INHIBITORS ICAGEN, INC. (US) 2009-01-22 WO disclosed